ir revamedical.com

Investor Relations REVA Medical

View REVA Medicals Investor Relations. Contact us at 1-858-966-3000 or inforevamedical.com to learn more.
traffic

OVERVIEW

This web site ir.revamedical.com presently has a traffic ranking of zero (the smaller the more users). We have researched eighteen pages inside the web site ir.revamedical.com and found twelve websites referencing ir.revamedical.com. I acquired two social communication sites linked to ir.revamedical.com.
Pages Analyzed
18
Links to this site
12
Social Links
2

IR.REVAMEDICAL.COM RANKINGS

This web site ir.revamedical.com is seeing a alternation quantities of traffic in the past the year.
Traffic for ir.revamedical.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.revamedical.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.revamedical.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO BUSINESS

WHAT DOES IR.REVAMEDICAL.COM LOOK LIKE?

Desktop Screenshot of ir.revamedical.com Mobile Screenshot of ir.revamedical.com Tablet Screenshot of ir.revamedical.com

IR.REVAMEDICAL.COM HOST

Our web crawlers revealed that the main page on ir.revamedical.com took three hundred and fifty-four milliseconds to download. We could not observe a SSL certificate, so I consider this site not secure.
Load time
0.354 seconds
SSL
NOT SECURE
Internet Address
23.213.123.49

BOOKMARK ICON

SERVER OPERATING SYSTEM AND ENCODING

I found that ir.revamedical.com is implementing the nginx server.

TITLE

Investor Relations REVA Medical

DESCRIPTION

View REVA Medicals Investor Relations. Contact us at 1-858-966-3000 or inforevamedical.com to learn more.

CONTENT

This web site had the following on the homepage, "REVA Medical is a medical device company focused on the development and commercialization of bioresorbable polymer technologies for vascular applications." Our analyzers saw that the web site said " The Companys lead product, the Fantom bioresorbable scaffold, received European CE Mark on April 3, 2017 for the treatment of coronary artery disease." The Website also said " Mar 30, 2018 1226 AM EDT. 10 CDIs equivalent to one share of common stock. REVA Announces First Implant of Fantom Encore in Switzerland."

SIMILAR BUSINESSES

INVESTOR RELATIONS Rex Energy Corporation

Rex Energy Announces Fourth Quarter and Full Year 2017 Production and Estimated Price Realizations and Provides Operational Update. Rex Energy Appoints New Chief Financial Officer. Rex Energy Announces Sale of Non-Operated Oil and Gas Interests in Westmoreland, Centre and Clearfield Counties. Rex Energy Appoints New Chief Financial Officer.

Q4 Web Site Development

This site is currently under development and not yet available for public viewing. For more information on why this site is not available, please contact Q4.

Rhino Resources - Investor Relations

Rhino Resource Partners LP Announces Second Quarter 2015 Financial and Operating Results. Rhino Resource Partners LP Announces Suspension of Second Quarter Distribution and Timing of Earnings Release Date. Rhino Resource Partners LP Temporarily Idling Majority of Central Appalachia Operations. Rhino Resource Partners LP Announces First Quarter 2015 Financial and Operating Results. There are currently no events scheduled.

Investor Relations - M.D.C. Holdings, Inc.

Quotes delayed at least 20 minutes. Equal Housing Opportunity 2015 M.